Type 1 diabetes mellitus with diabetic peripheral angiopathy without gangrene
ICD-10 E10.51 is a billable code used to indicate a diagnosis of type 1 diabetes mellitus with diabetic peripheral angiopathy without gangrene.
E10.51 refers to Type 1 diabetes mellitus characterized by the presence of diabetic peripheral angiopathy, which is a complication that affects the blood vessels in the extremities, leading to reduced blood flow. This condition occurs without the presence of gangrene, which is a severe complication that involves tissue death due to lack of blood supply. Patients with Type 1 diabetes often experience elevated blood glucose levels, which can lead to vascular damage over time. The management of this condition typically involves strict glycemic control, often monitored through HbA1c levels, which should ideally be maintained below 7% to prevent further complications. Insulin therapy is the cornerstone of treatment for Type 1 diabetes, and patients may require multiple daily injections or an insulin pump to achieve optimal control. Diabetic peripheral angiopathy can lead to symptoms such as pain, numbness, and weakness in the legs and feet, increasing the risk of ulcers and infections. Regular monitoring and preventive care are essential to manage this condition effectively and to mitigate the risk of more severe complications.
Detailed records of diabetes management, including insulin regimens and HbA1c levels.
Patients presenting with uncontrolled diabetes and complications such as neuropathy or angiopathy.
Ensure clear documentation of all diabetes-related complications and treatment plans.
Foot examinations and assessments of peripheral circulation.
Patients with foot ulcers or infections due to diabetic complications.
Document the absence of gangrene and any interventions performed.
Used for routine follow-up visits for diabetes management.
Document the patient's diabetes management plan and any complications.
Endocrinologists should ensure comprehensive documentation of diabetes control.
HbA1c levels provide an average of blood glucose control over the past 2-3 months, helping to assess the effectiveness of diabetes management and adjust treatment plans accordingly.
